Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Proteasome Inhibitor Drugs
Lloyd D. Fricker
Molecular Pharmacology
Research output
:
Contribution to journal
›
Review article
›
peer-review
107
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Proteasome Inhibitor Drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Proteasome Inhibitors
79%
ixazomib
58%
carfilzomib
53%
Proteasome Endopeptidase Complex
52%
Bortezomib
40%
Pharmaceutical Preparations
27%
Mantle-Cell Lymphoma
21%
Protein Subunits
19%
Proteins
18%
United States Food and Drug Administration
16%
Multiple Myeloma
16%
Cell Death
12%
Peptides
10%
Therapeutics
2%
Chemical Compounds
Proteasome Inhibitor
100%
Ixazomib
36%
Drug
35%
Carfilzomib
32%
Bortezomib
27%
Protein
27%
Cell Death
17%
Peptide
9%